Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators

BACKGROUND: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulations changed to allow community-based prescribing and supply of clozapine for ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Bethany, McMillan, Sara S., Wheeler, Amanda J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685252/
https://www.ncbi.nlm.nih.gov/pubmed/31406580
http://dx.doi.org/10.1186/s40545-019-0180-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685252/
https://www.ncbi.nlm.nih.gov/pubmed/31406580
http://dx.doi.org/10.1186/s40545-019-0180-3

Ejemplares similares